Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisation

Daniek P J Slegers1, Roberto Bova2, Samuel F M Heuts3

  • 1Department of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands.

PubMed

Insights

Intracoronary pullback measurements reveal lesion morphology significantly impacts treatment decisions in stable coronary artery disease (CAD), often prioritizing morphology over functional severity for interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Accurate assessment of coronary artery disease (CAD) lesion severity and distribution is crucial for optimal treatment selection.
  • Intracoronary pullback measurements are increasingly used, but their impact on clinical decision-making remains unclear.

Purpose of the Study:

  • To investigate the influence of intracoronary pullback-derived lesion morphology on treatment strategies in stable CAD.
  • To determine if lesion morphology independently affects treatment decisions beyond functional severity.

Main Methods:

  • Retrospective single-centre cohort study of 303 patients with stable CAD undergoing intracoronary pullback measurement.
  • Classification of lesions as focal or diffuse based on pullback data.
  • Analysis of treatment strategies (optimal medical therapy, percutaneous coronary intervention, coronary artery bypass grafting) and one-year clinical outcomes.

Main Results:

  • Diffuse disease (71%) was more common than focal disease (29%).
  • Focal lesions were more likely treated with percutaneous coronary intervention (PCI), while diffuse lesions often received optimal medical therapy (OMT), even with significant ischemia (FFR ≤0.75).
  • Lesion morphology, fractional flow reserve (FFR), and symptom burden independently predicted treatment decisions.

Conclusions:

  • Intracoronary pullback-derived lesion morphology is an independent factor influencing treatment decisions in stable CAD.
  • Diffuse coronary artery disease morphology frequently leads to deferral of revascularization, irrespective of functional severity.
  • Lesion morphology can outweigh functional severity in guiding treatment choices for stable CAD.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
290
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
219